Clinical Trials Insight: 700034403
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2010
At a glance
- Drugs Zaleplon (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors SkyePharma PLC; Somnus Therapeutics
- 10 Jun 2010 Results have been presented at the Association of Professional Sleep Societies 24th Annual Meeting, according to a Somnus Therapeutics media release. Results were discussed further in the media release.
- 11 Dec 2008 Status changed from recruiting to completed.
- 11 Jun 2008 New trial record.